or Try an Advanced Search...

    Diabetes Care Stocks List

    Symbol Grade Name % Change
    PRGO F Perrigo Company -1.97
    TNDM B Tandem Diabetes Care, Inc. -0.26
    NVO A Novo Nordisk A/S 0.01
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene

    Related ETFs - A few ETFs which own one or more of the above listed Diabetes Care stocks.

    Symbol Grade Name Weight
    EDEN B iShares MSCI Denmark Capped ETF 23.27
    OZEM A Roundhill GLP-1 & Weight Loss ETF 20.52
    THNR B Amplify Weight Loss Drug & Treatment ETF 14.9
    PPH A Market Vectors Pharmaceutical ETF 10.88
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.71
    View all Diabetes Care ETFs...
    Compare ETFs
    Compare OZEM to IGTR Compare PPH to IGTR Compare THNR to IGTR

        Diabetes Care Stocks Recent News

        Date Stock Title
        Jun 15 NVO Novo Nordisk CEO to testify before Senate on Ozempic pricing
        Jun 15 NVO 3 Growth Stocks You Can Buy Right Now Without Any Hesitation
        Jun 14 NVO Employee benefits survey finds marked increase in GLP-1 coverage
        Jun 14 NVO Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
        Jun 14 NVO Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
        Jun 14 NVO Eli Lilly unveils new manufacturing plant for GLP-1 pens
        Jun 14 NVO IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
        Jun 14 NVO Few IBD 50 Stocks In Buy Zones; Netflix Is One
        Jun 14 NVO Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
        Jun 14 NVO Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market
        Jun 14 NVO Employer coverage for GLP-1s rising amid FDA label expansions: survey
        Jun 14 NVO Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
        Jun 14 NVO Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
        Jun 12 NVO Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan
        Jun 12 NVO ASML, Novo Nordisk, Spotify Boast This Sign Of Stock Market Leadership
        Jun 12 NVO GLP-1 obesity drug coverage dropped by Blue Cross Michigan: report
        Jun 12 NVO Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
        Jun 12 NVO Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
        Jun 12 NVO Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
        Jun 11 NVO Update: Novo Nordisk to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene
        Diabetes Care

        Diabetes Care is a monthly peer-reviewed medical journal published since 1978 by the American Diabetes Association. The journal covers research in the following five categories: 1) clinical care/education/nutrition/psychosocial research, 2) epidemiology/health services research, 3) emerging treatments and technologies, 4) pathophysiology/complications, and 5) cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries.According to the Journal Citation Reports, the journal has a 2017 impact factor of 13.397 ranking it fifth out of 138 journals in the category "Endocrinology & Metabolism."

        More about Diabetes Care
        Browse All Tags